Free Trial

InnovAge (INNV) Expected to Announce Earnings on Tuesday

InnovAge logo with Medical background

Key Points

  • InnovAge (INNV) is set to release its Q4 2025 earnings on September 9th, with analysts predicting a loss of ($0.02) per share and revenue of $219.796 million.
  • The stock is currently trading at $3.83, with a market cap of $517.09 million and a price-to-earnings ratio of -16.65.
  • Institutional investors recently increased their holdings in InnovAge, with notable investments from Bank of America and Goldman Sachs, indicating growing interest in the company.
  • Interested in InnovAge? Here are five stocks we like better.

InnovAge (NASDAQ:INNV - Get Free Report) is expected to post its Q4 2025 results after the market closes on Tuesday, September 9th. Analysts expect InnovAge to post earnings of ($0.02) per share and revenue of $219.7960 million for the quarter. Individuals can find conference call details on the company's upcoming Q4 2025 earningreport page for the latest details on the call scheduled for Tuesday, September 9, 2025 at 5:00 PM ET.

InnovAge Price Performance

INNV opened at $3.83 on Tuesday. The stock has a market cap of $517.09 million, a price-to-earnings ratio of -16.65 and a beta of 0.52. InnovAge has a 1 year low of $2.60 and a 1 year high of $6.69. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.04. The stock has a fifty day moving average price of $3.80 and a 200 day moving average price of $3.53.

Institutional Trading of InnovAge

A number of institutional investors have recently bought and sold shares of INNV. Bank of America Corp DE boosted its position in InnovAge by 42.4% during the fourth quarter. Bank of America Corp DE now owns 19,945 shares of the company's stock valued at $78,000 after purchasing an additional 5,936 shares during the last quarter. Jane Street Group LLC lifted its position in shares of InnovAge by 18.9% in the first quarter. Jane Street Group LLC now owns 46,827 shares of the company's stock worth $140,000 after buying an additional 7,429 shares during the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in shares of InnovAge in the first quarter worth about $166,000. Strs Ohio acquired a new stake in shares of InnovAge in the first quarter worth about $186,000. Finally, Goldman Sachs Group Inc. lifted its position in shares of InnovAge by 41.2% in the first quarter. Goldman Sachs Group Inc. now owns 94,831 shares of the company's stock worth $283,000 after buying an additional 27,674 shares during the last quarter. Institutional investors and hedge funds own 12.26% of the company's stock.

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Featured Stories

Earnings History for InnovAge (NASDAQ:INNV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in InnovAge Right Now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines